Business Opportunity

Operational in over 100 hospitals and 200 clinics, Universata has proven with its acquisitions, revenue analysis and real-time operational metrics that the superior technology embedded in its products generates higher EBITDA rates and better customer satisfaction than traditional copy service methods. We will use this experience to license our technology to the ROI industry (our competitors), to end users (self staffed hospitals and clinics) and to ERM (electronic medical records) vendors.

The utility and market recognition of our exchange technology is accelerated and made “evergreen” by Universata’s second disruptive technology, the Equivalents Engine (E2 - see Technology). This proprietary technology facilitates systems integrations necessary for the exchange of medical data (or any data in any industry) via a national exchange managed by Universata, i.e. the National Health Information Exchange (NHIE).

During the next two years, industry pressures brought about by calls for efficiencies and new services from Healthcare and ROI users, will cause ROI outsource vendors to be at a serious competitive risk technologically. Traditional sales relationships with HIM (Health Information Management) Directors will be of diminishing value as control of ROI contracts expand from the HIM Director to include senior healthcare executives who embrace enterprise wide solutions promoted by familiar, national vendor firms like Siemens Medical Solutions (SMS), a Universata partner.

Universata’s Alliance Program offers our superior technology to the small ROI vendor and with it, an opportunity to survive and aggregate via a powerful technology platform that will become the foundation for the national Health Information Exchange. The opportunity to create, manage and leverage this message to a vulnerable, fragmented industry is precisely now. The players are in position and the message is clear, proven and compelling.

The $1.6B ROI industry approximates $1B in annual, outsourced vendor revenue. Another $0.6B of revenue from currently self-staffed operations can be available to Universata and its licensees through its new small clinic product, Transfer IT and through licensing PHI-nd IT (see Technology) to self-staffed hospitals and large clinics. Beyond this initial ROI market opportunity are two conjunctive market opportunities that grow the overall market to $4.2B total. The linking of these 3 markets is unique to Universata’s technology and strategic initiatives.